Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up
Objective The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. Methods A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospitalization for COVID-19 examined included (1) sociodemographic variables (age, gender, education, tobacco use, socioeconomic status, and co-inhabitants), (2) comorbidities, (3) time to COVID-19 diagnosis, and (4) ARD’s features: clinical (disease type, disease duration, activity), treatment [corticosteroids use/doses, use of synthetic DMARDs (cDMARDs, tsDMARDs, and bDMARDs)], treatment schedule and non-adherence, and the Multidimensional Health Assessment Questionnaire (MDHAQ). Univariable and multivariable regression analysis were conducted; OR and 95% CI (p < 0.05) were determined. Results One thousand and one hundred forty-eight patients with ARDs were included; 154 had COVID-19; of these 139 (90.3%) were women, aged 52.5 (13.7) years; 33.1% had hypertension and 61.0% an affected organ by ARD. Infection was detected 8.4 (10.1) days after symptoms started; there were 33 hospitalized patients (rate 21.4%). Predictors of hospitalization by multivariable analysis were age (OR: 1.06; CI: 1.01–1.10; p: 0.01), comorbidities: hypertension (OR: 3.95; 95% CI: 1.40–10.95, p: 0.01) and neoplasm (OR: 9.0; 95% CI: 1.6–52.3; p: 0.01), number of organs involved by ARD (OR: 2.26; 95% CI: 1.16–4.41; p: 0.02), and infection diagnosis delay (OR: 1.36; 95% CI: 1.03–1.80; p: 0.01). Conclusions In our ARD patients with COVID-19, older age, comorbidities (neoplasm and hypertension), and a delay in COVID-19 diagnosis were predictors of hospitalization. The only ARD-associated predictor feature was the number of organs involved.Key Points• Patients with ARD and COVID-19 have an adverse course in comparison to the general population.• Previous predictors of COVID-19 hospitalization, including known risk factors (such as older age and comorbidities) and systemic manifestations, should be taken into account in the management of these patients.• Delayed diagnosis of COVID-19 impacts negatively on prognosis.• Availability of diagnostic tests is of utmost importance..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Clinical rheumatology - 40(2021), 11 vom: 30. Juni, Seite 4725-4734 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gamboa-Cárdenas, Rocío-V. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Autoimmune rheumatic disease |
Anmerkungen: |
© International League of Associations for Rheumatology (ILAR) 2021 |
---|
doi: |
10.1007/s10067-021-05833-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR045300364 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR045300364 | ||
003 | DE-627 | ||
005 | 20230520005308.0 | ||
007 | cr uuu---uuuuu | ||
008 | 211016s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10067-021-05833-1 |2 doi | |
035 | |a (DE-627)SPR045300364 | ||
035 | |a (SPR)s10067-021-05833-1-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.00 |2 bkl | ||
084 | |a 44.83 |2 bkl | ||
100 | 1 | |a Gamboa-Cárdenas, Rocío-V. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © International League of Associations for Rheumatology (ILAR) 2021 | ||
520 | |a Objective The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. Methods A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospitalization for COVID-19 examined included (1) sociodemographic variables (age, gender, education, tobacco use, socioeconomic status, and co-inhabitants), (2) comorbidities, (3) time to COVID-19 diagnosis, and (4) ARD’s features: clinical (disease type, disease duration, activity), treatment [corticosteroids use/doses, use of synthetic DMARDs (cDMARDs, tsDMARDs, and bDMARDs)], treatment schedule and non-adherence, and the Multidimensional Health Assessment Questionnaire (MDHAQ). Univariable and multivariable regression analysis were conducted; OR and 95% CI (p < 0.05) were determined. Results One thousand and one hundred forty-eight patients with ARDs were included; 154 had COVID-19; of these 139 (90.3%) were women, aged 52.5 (13.7) years; 33.1% had hypertension and 61.0% an affected organ by ARD. Infection was detected 8.4 (10.1) days after symptoms started; there were 33 hospitalized patients (rate 21.4%). Predictors of hospitalization by multivariable analysis were age (OR: 1.06; CI: 1.01–1.10; p: 0.01), comorbidities: hypertension (OR: 3.95; 95% CI: 1.40–10.95, p: 0.01) and neoplasm (OR: 9.0; 95% CI: 1.6–52.3; p: 0.01), number of organs involved by ARD (OR: 2.26; 95% CI: 1.16–4.41; p: 0.02), and infection diagnosis delay (OR: 1.36; 95% CI: 1.03–1.80; p: 0.01). Conclusions In our ARD patients with COVID-19, older age, comorbidities (neoplasm and hypertension), and a delay in COVID-19 diagnosis were predictors of hospitalization. The only ARD-associated predictor feature was the number of organs involved.Key Points• Patients with ARD and COVID-19 have an adverse course in comparison to the general population.• Previous predictors of COVID-19 hospitalization, including known risk factors (such as older age and comorbidities) and systemic manifestations, should be taken into account in the management of these patients.• Delayed diagnosis of COVID-19 impacts negatively on prognosis.• Availability of diagnostic tests is of utmost importance. | ||
650 | 4 | |a Autoimmune rheumatic disease |7 (dpeaa)DE-He213 | |
650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
650 | 4 | |a COVID-19 adverse predictors |7 (dpeaa)DE-He213 | |
650 | 4 | |a SARS-CoV-2 |7 (dpeaa)DE-He213 | |
700 | 1 | |a Barzola-Cerrón, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Toledo-Neira, Denisse |e verfasserin |4 aut | |
700 | 1 | |a Reátegui-Sokolova, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Pimentel-Quiroz, Víctor |e verfasserin |4 aut | |
700 | 1 | |a Zevallos-Miranda, Francisco |e verfasserin |4 aut | |
700 | 1 | |a Alarcón, Graciela S. |e verfasserin |4 aut | |
700 | 1 | |a Ugarte-Gil, Manuel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical rheumatology |d London : Springer, 1982 |g 40(2021), 11 vom: 30. Juni, Seite 4725-4734 |w (DE-627)SPR008480389 |w (DE-600)1480901-1 |x 1434-9949 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2021 |g number:11 |g day:30 |g month:06 |g pages:4725-4734 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10067-021-05833-1 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.00 |q ASE |
936 | b | k | |a 44.83 |q ASE |
951 | |a AR | ||
952 | |d 40 |j 2021 |e 11 |b 30 |c 06 |h 4725-4734 |